Latest Advances

  • Condition: Breast Cancer
  • Journal: BMC cancer
  • Treatment Used: PDLASTA® (Pegfilgrastim) vs. PDGRASTIM® (Filgrastim)
  • Number of Patients: 80
  • Published —
This study compared the effectiveness and side effects of a single dose (Pegfilgrastim or PDL) or repeated six daily injections (Filgrastim or PDG) during chemotherapy in patients with breast cancer.
  • Condition: Locally Advanced or Metastatic Breast Cancer
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: PARP (Poly ADP-Ribose Polymerase) Inhibitors
  • Published —
This review of the literature sought to determine the safety, effectiveness, and possible harms of poly(ADP-Ribose) polymerase (PARP) inhibitors in the treatment of patients with locally advanced or metastatic breast cancer.
  • Condition: Patients with Both Cardiac and Non-Cardiac Diseases
  • Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
  • Treatment Used: One-Stage Surgery
  • Number of Patients: 111
  • Published —
This study investigated the feasibility of one-stage cardiac and non-cardiac surgery in patients with both cardiac and non-cardiac diseases.
  • Condition: Metastatic Triple-Negative Breast Cancer
  • Journal: The New England journal of medicine
  • Treatment Used: Sacituzumab Govitecan
  • Number of Patients: 468
  • Published —
The aim of this study was to evaluate sacituzumab govitecan as compared with single-agent chemotherapy in patients with relapsed or refractory metastatic triple-negative breast cancer.
  • Condition: Metastatic Breast Cancer (MBC)
  • Journal: JAMA network open
  • Treatment Used: Weekly Paclitaxel with or without Oral Alisertib
  • Number of Patients: 174
  • Published —
This study compared paclitaxel alone versus paclitaxel plus alisertib in the treatment of patients with ER-positive and ERBB2-negative or triple-negative metastatic breast cancer (MBC).
  • Condition: Platinum-Resistant Ovarian Cancer (PROC)
  • Journal: JCO global oncology
  • Treatment Used: PARP Inhibitor
  • Number of Patients: 28
  • Published —
This study reported the outcome of treatment with poly (ADP-ribose) polymerase inhibitors (PARPi) in patients with platinum-resistant ovarian cancer (PROC).
  • Condition: Cancer
  • Journal: Cells
  • Treatment Used: Targeted Therapies
  • Number of Patients: 0
  • Published —
This article provides an updated review for current targeted therapies for cancer treatment.
  • Condition: Patients with Breast Cancer Receiving Anthracycline-Containing Chemotherapy
  • Journal: BMC cancer
  • Treatment Used: Recombinant Human Serum Albumin /Granulocyte Colony-Stimulating Factor (rHSA/G-CSF)
  • Number of Patients: 320
  • Published —
This study evaluate the safety and effectiveness of recombinant human serum albumin /granulocyte colony-stimulating factor (rHSA/G-CSF) in patients with breast cancer after receiving cytotoxic agents.
  • Journal: Gan to kagaku ryoho. Cancer & chemotherapy
  • Published —
Five Patients with Gastric Metastasis from Breast Cancer-A Case Report
  • Journal: Medicine
  • Published —
Refusal of cancer-directed surgery in male breast cancer.
Showing 1-12 of 1839